RONNIE TEPP — Lobbyist Profile | Poliscope

RONNIE TEPP

Filings

Clients

Firms

Years active

2009–2009

Associated filing income

—

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
COALITION FOR THE ADVANCEMENT OF MEDICAL RESEARCH	4	2009

Lobbying firms

Firm	Filings	Years
NAVIGATOR CONSULTING	4	2009

Bills explicitly cited in this lobbyist’s assigned issues (8)

No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.

H.R. 872

Stem Cell Research Improvement Act of 2009

Client: COALITION FOR THE ADVANCEMENT OF MEDICAL RESEARCH · Firm: NAVIGATOR CONSULTING

Open original LDA filing ↗

Cited source text

H.R. 872, To amend the Public Health Service Act to provide for human embryonic stem cell research H.R. 873, To amend the Public Health Service Act to provide for human embryonic stem cell research S. 487, A bill to amend the Public Health Service Act to provide for human embyronic stem cell research

H.R. 872

Stem Cell Research Improvement Act of 2009

Client: COALITION FOR THE ADVANCEMENT OF MEDICAL RESEARCH · Firm: NAVIGATOR CONSULTING

Open original LDA filing ↗

Cited source text

Original LDA source filings (4)

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

COALITION FOR THE ADVANCEMENT OF MEDICAL RESEARCH via NAVIGATOR CONSULTING

2009 · third_quarter · Q3

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

MED

Medical/Disease Research/Clinical Labs

H.R.872, to amend the Public Health Service Act to provide for human embryonic stem cell research H.R.873, to amend the Public Health Service Act to provide for human embryonic stem cell research

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

COALITION FOR THE ADVANCEMENT OF MEDICAL RESEARCH via NAVIGATOR CONSULTING

2009 · second_quarter · Q2

Source: Senate LDA